Company / Net Debt per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Net Debt per Share History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$27.43
FY2017
5-year range
-
FY2016-FY2017
Trend
-100.0%
vs FY2016
Sector context
#8 of 82
Health Care
What the data says
Among 82 Health Care companies, TEVA PHARMACEUTICAL INDUSTRIES LTD is in the bottom 10% for net debt per share.
Based on SEC 10-K filings.
27.43 in FY2017. Top quartile in the Health Care sector.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 82This company $27.43 Sector average $1.13
▼
+2326.7% above sector average
Key checks
Key Insights
- In FY2017, net debt per share decreased 100.0% year-over-year.
- Ranks #8 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $27.43 | -100.0% |
| FY2016 | $32815816.86 | - |
As of FY2017 · SEC 10-K · Updated Mar 28, 2026